Free Trial
Anthony Vendetti

Anthony Vendetti Analyst Performance

Executive Managing Director of Research at Maxim Group

Anthony Vendetti is a stock analyst at Maxim Group focused in the medical sector, covering 44 publicly traded companies. Over the past year, Anthony Vendetti has issued 17 stock ratings, including strong buy, buy, and hold recommendations. While full access to Anthony Vendetti's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Anthony Vendetti's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
129 Last 11 Years
Buy Recommendations
92.86% 117 Buy Ratings
Companies Covered
44 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.8%1 ratings
Buy92.1%116 ratings
Hold7.1%9 ratings
Sell0.0%0 ratings

Out of 126 total stock ratings issued by Anthony Vendetti at Maxim Group, the majority (92.1%) have been Buy recommendations, followed by 7.1% Hold and 0.8% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
79.5% of companies on NASDAQ
35 companies
NYSEAMERICAN
11.4% of companies on NYSEAMERICAN
5 companies
OTCMKTS
4.5% of companies on OTCMKTS
2 companies
NYSE
4.5% of companies on NYSE
2 companies

Anthony Vendetti, an analyst at Maxim Group, currently covers 44 companies listed on NASDAQ, NYSEAMERICAN, OTCMKTS and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
31 companies
70.5%
Consumer Staples
8 companies
18.2%
Miscellaneous
2 companies
4.5%
Computer and Technology
1 company
2.3%
Industrials
1 company
2.3%
Consumer Defensive
1 company
2.3%

Anthony Vendetti of Maxim Group specializes in stock coverage within the Medical sector, with additional focus on Consumer Staples and companies.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
6 companies
13.6%
MEDICAL SERVICES
4 companies
9.1%
BEVERAGES - SOFT
3 companies
6.8%
FOOD - MISC/DIVERSIFIED
3 companies
6.8%
PHARMACEUTICAL PREPARATIONS
3 companies
6.8%
SURGICAL & MEDICAL INSTRUMENTS
3 companies
6.8%
MED - BIOMED/GENE
2 companies
4.5%
ELECTROMEDICAL EQUIPMENT
2 companies
4.5%
MEDICAL DEVICES
2 companies
4.5%
MED - HMO
2 companies
4.5%
Miscellaneous
2 companies
4.5%
MED PRODUCTS
1 company
2.3%
MEDICAL INFO SYS
1 company
2.3%
MEDICAL INSTRUMENTS & SUPPLIES
1 company
2.3%
DENTAL EQUIPMENT & SUPPLIES
1 company
2.3%
MED - DRUGS
1 company
2.3%
PROTECTION - SFTY
1 company
2.3%
SURGICAL APPLIANCES & SUPPLIES
1 company
2.3%
BIOTECHNOLOGY
1 company
2.3%
AGRICULTURAL PRODUCTION - CROPS
1 company
2.3%
MALT BEVERAGES
1 company
2.3%
BEVERAGES - WINERIES & DISTILLERS
1 company
2.3%
DRUG STORES & PROPRIETARY STORES
1 company
2.3%

About Anthony Vendetti

Anthony Vendetti is the Director of Research and Senior Healthcare Analyst at Maxim Group, LLC. Mr. Vendetti has been on Wall Street for more than 20 years and follows the aesthetic device, health & wellness, healthcare information technology & services, and medical device industries.Prior to joining Maxim Group, he was a senior healthcare analyst at Gruntal, UBS Securities and Ladenburg Thalmann. Mr. Vendetti also worked for three years in the healthcare industry at CIGNA, ultimately as a senior healthcare analyst in the managed care division. Mr. Vendetti earned his M.B.A. in finance and accounting from Rensselaer Polytechnic Institute, and his B.S. degree in biology from Binghamton University. While at Binghamton, Mr. Vendetti was pre-med, earned his emergency medical technician (EMT) certification and was a member of the Binghamton volunteer ambulance core. Mr. Vendetti has been a guest speaker on CNNfn, CNN MoneyLine, and a member of investment panels at various healthcare conferences nationwide. In addition, he has been quoted in numerous healthcare journals and financial publications such as Business Week, Forbes, Investor's Business Daily and The Wall Street Journal. On June 26, 2001, The Wall Street Journal ranked Mr. Vendetti as one of the best stock-picking analysts in its annual 2000 Best on the Street survey. Moreover, on May 2, 2006, Forbes.com/StarMine ranked Mr. Vendetti as the #3 ranked Healthcare Equipment and Supplies Analyst and the #8 ranked analyst out of 3,400 sell-side analysts on Wall Street in terms of total return (stock picking) for 2005. In addition, on May 22, 2006, The Wall Street Journal ranked Mr. Vendetti as the #3 ranked analyst in the Medical Equipment industry in its annual 2005 Best on the Street survey.
Follow on LinkedIn

Anthony Vendetti's Ratings History at Maxim Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Barfresh Food Group Inc. stock logo
BRFH
Barfresh Food Group
9/19/2025Boost Price Target$4.31$6.00Buy
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
9/9/2025Initiated Coverage$0.90$3.00Buy
Nutex Health Inc. stock logo
NUTX
Nutex Health
8/26/2025Set Price Target$84.51$205.00Buy
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
8/21/2025Lower Price Target$5.35$10.00Buy
Celsius Holdings Inc. stock logo
CELH
Celsius
8/8/2025Boost Price Target$51.95$65.00Buy
Nephros Inc. stock logo
NEPH
Nephros
8/8/2025Boost Price Target$3.90$6.00Buy
Laird Superfood, Inc. stock logo
LSF
Laird Superfood
6/30/2025Upgrade$6.48$12.00Strong-Buy
Dermata Therapeutics, Inc. stock logo
DRMA
Dermata Therapeutics
5/21/2025Lower Price Target$7.87$30.00Buy
Nutex Health Inc. stock logo
NUTX
Nutex Health
5/20/2025Boost Price Target$177.60$225.00Buy
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
5/19/2025Lower Price Target$4.39$10.00Buy
The Hain Celestial Group, Inc. stock logo
HAIN
The Hain Celestial Group
5/8/2025Lower Price Target$1.53$5.00Buy
Autonomix Medical, Inc. stock logo
AMIX
Autonomix Medical
4/29/2025Initiated Coverage$2.51$5.00Buy
Nutex Health Inc. stock logo
NUTX
Nutex Health
4/8/2025Boost Price Target$84.94$100.00Buy
bioAffinity Technologies, Inc. stock logo
BIAF
bioAffinity Technologies
4/1/2025Reiterated Rating$0.26Hold
Healthy Choice Wellness Corp. stock logo
HCWC
Healthy Choice Wellness
3/7/2025Initiated Coverage$0.51$2.00Buy
Strata Skin Sciences, Inc. stock logo
SSKN
Strata Skin Sciences
2/27/2025Initiated Coverage$2.70$6.00Buy
The Hain Celestial Group, Inc. stock logo
HAIN
The Hain Celestial Group
2/11/2025Lower Price Target$4.08$10.00Buy